Michael Mollerus

Davis Polk is advising Shire plc on the $2.4 billion sale of its Oncology business to Servier S.A.S. The transaction has been approved by the board of directors and is expected to close in…

Davis Polk advised MSCI Inc. in connection with the sale of Financial Engineering Associates, Inc., a wholly owned subsidiary of MSCI, to Allegro Development Corporation. The terms of the…

Davis Polk advised Fogo de Chão, Inc. on the closing of its $560 million acquisition by Rhône Capital. Fogo de Chão is a Brazilian steakhouse operator with locations in Brazil, the United…

Davis Polk advised SS&C Technologies Holdings, Inc. on its $1.4 billion public offering of 30,262,250 shares of common stock, including 3,947,250 shares sold pursuant to an underwriters…

Davis Polk advised Charles River Laboratories International, Inc. in connection with its Rule 144A/Regulation S offering of $500 million aggregate principal amount of 5.500% senior notes…

Davis Polk advised Valeant Pharmaceuticals International, Inc. (“Valeant”) in connection with a refinancing transaction pursuant to which its indirect wholly owned subsidiary, Valeant…

Davis Polk advised the underwriter in connection with the SEC-registered offering of 4,179,678 shares of common stock of OneMain Holdings, Inc. sold by Springleaf Financial Holdings, LLC on…

Davis Polk is advising Fogo de Chão, Inc. on its $560 million acquisition by Rhône Capital. The transaction is expected to be completed during the second quarter of 2018, subject to…

Davis Polk advised Affimed N.V. on its $26.5 million public offering of 13,225,000 of its common shares. Included in the shares are 1,725,000 shares sold by Affimed pursuant to the…

Davis Polk advised EnVen Energy Corporation in connection with a Rule 144A/Regulation S offering of $325 million aggregate principal amount of its 11.000% senior secured second-lien notes…